3D bioprinting of skin tissue: From pre-processing to final product evaluation

Wei Cheng Yan, Pooya Davoodi, Sanjairaj Vijayavenkataraman, Yuan Tian, Wei Cheng Ng, Jerry Y.H. Fuh, Kim Samirah Robinson, Chi Hwa Wang

Research output: Contribution to journalReview article

Abstract

Bioprinted skin tissue has the potential for aiding drug screening, formulation development, clinical transplantation, chemical and cosmetic testing, as well as basic research. Limitations of conventional skin tissue engineering approaches have driven the development of biomimetic skin equivalent via 3D bioprinting. A key hope for bioprinting skin is the improved tissue authenticity over conventional skin equivalent construction, enabling the precise localization of multiple cell types and appendages within a construct. The printing of skin faces challenges broadly associated with general 3D bioprinting, including the selection of cell types and biomaterials, and additionally requires in vitro culture formats that allow for growth at an air-liquid interface. This paper provides a thorough review of current 3D bioprinting technologies used to engineer human skin constructs and presents the overall pipelines of designing a biomimetic artificial skin via 3D bioprinting from the design phase (i.e. pre-processing phase) through the tissue maturation phase (i.e. post-processing) and into final product evaluation for drug screening, development, and drug delivery applications.

Original languageEnglish (US)
Pages (from-to)270-295
Number of pages26
JournalAdvanced Drug Delivery Reviews
Volume132
DOIs
StatePublished - Jul 1 2018

Fingerprint

Bioprinting
Skin
Biomimetics
Preclinical Drug Evaluations
Artificial Skin
Drug Compounding
Printing
Biocompatible Materials
Tissue Engineering
Cosmetics
Transplantation
Air
Technology

Keywords

  • 3D bioprinting
  • Artificial skin
  • Skin tissue engineering
  • Tissue engineering

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Yan, W. C., Davoodi, P., Vijayavenkataraman, S., Tian, Y., Ng, W. C., Fuh, J. Y. H., ... Wang, C. H. (2018). 3D bioprinting of skin tissue: From pre-processing to final product evaluation. Advanced Drug Delivery Reviews, 132, 270-295. https://doi.org/10.1016/j.addr.2018.07.016

3D bioprinting of skin tissue : From pre-processing to final product evaluation. / Yan, Wei Cheng; Davoodi, Pooya; Vijayavenkataraman, Sanjairaj; Tian, Yuan; Ng, Wei Cheng; Fuh, Jerry Y.H.; Robinson, Kim Samirah; Wang, Chi Hwa.

In: Advanced Drug Delivery Reviews, Vol. 132, 01.07.2018, p. 270-295.

Research output: Contribution to journalReview article

Yan, WC, Davoodi, P, Vijayavenkataraman, S, Tian, Y, Ng, WC, Fuh, JYH, Robinson, KS & Wang, CH 2018, '3D bioprinting of skin tissue: From pre-processing to final product evaluation', Advanced Drug Delivery Reviews, vol. 132, pp. 270-295. https://doi.org/10.1016/j.addr.2018.07.016
Yan, Wei Cheng ; Davoodi, Pooya ; Vijayavenkataraman, Sanjairaj ; Tian, Yuan ; Ng, Wei Cheng ; Fuh, Jerry Y.H. ; Robinson, Kim Samirah ; Wang, Chi Hwa. / 3D bioprinting of skin tissue : From pre-processing to final product evaluation. In: Advanced Drug Delivery Reviews. 2018 ; Vol. 132. pp. 270-295.
@article{9276d8bcefea4144a13fd9bb817a7c11,
title = "3D bioprinting of skin tissue: From pre-processing to final product evaluation",
abstract = "Bioprinted skin tissue has the potential for aiding drug screening, formulation development, clinical transplantation, chemical and cosmetic testing, as well as basic research. Limitations of conventional skin tissue engineering approaches have driven the development of biomimetic skin equivalent via 3D bioprinting. A key hope for bioprinting skin is the improved tissue authenticity over conventional skin equivalent construction, enabling the precise localization of multiple cell types and appendages within a construct. The printing of skin faces challenges broadly associated with general 3D bioprinting, including the selection of cell types and biomaterials, and additionally requires in vitro culture formats that allow for growth at an air-liquid interface. This paper provides a thorough review of current 3D bioprinting technologies used to engineer human skin constructs and presents the overall pipelines of designing a biomimetic artificial skin via 3D bioprinting from the design phase (i.e. pre-processing phase) through the tissue maturation phase (i.e. post-processing) and into final product evaluation for drug screening, development, and drug delivery applications.",
keywords = "3D bioprinting, Artificial skin, Skin tissue engineering, Tissue engineering",
author = "Yan, {Wei Cheng} and Pooya Davoodi and Sanjairaj Vijayavenkataraman and Yuan Tian and Ng, {Wei Cheng} and Fuh, {Jerry Y.H.} and Robinson, {Kim Samirah} and Wang, {Chi Hwa}",
year = "2018",
month = "7",
day = "1",
doi = "10.1016/j.addr.2018.07.016",
language = "English (US)",
volume = "132",
pages = "270--295",
journal = "Advanced Drug Delivery Reviews",
issn = "0169-409X",
publisher = "Elsevier",

}

TY - JOUR

T1 - 3D bioprinting of skin tissue

T2 - From pre-processing to final product evaluation

AU - Yan, Wei Cheng

AU - Davoodi, Pooya

AU - Vijayavenkataraman, Sanjairaj

AU - Tian, Yuan

AU - Ng, Wei Cheng

AU - Fuh, Jerry Y.H.

AU - Robinson, Kim Samirah

AU - Wang, Chi Hwa

PY - 2018/7/1

Y1 - 2018/7/1

N2 - Bioprinted skin tissue has the potential for aiding drug screening, formulation development, clinical transplantation, chemical and cosmetic testing, as well as basic research. Limitations of conventional skin tissue engineering approaches have driven the development of biomimetic skin equivalent via 3D bioprinting. A key hope for bioprinting skin is the improved tissue authenticity over conventional skin equivalent construction, enabling the precise localization of multiple cell types and appendages within a construct. The printing of skin faces challenges broadly associated with general 3D bioprinting, including the selection of cell types and biomaterials, and additionally requires in vitro culture formats that allow for growth at an air-liquid interface. This paper provides a thorough review of current 3D bioprinting technologies used to engineer human skin constructs and presents the overall pipelines of designing a biomimetic artificial skin via 3D bioprinting from the design phase (i.e. pre-processing phase) through the tissue maturation phase (i.e. post-processing) and into final product evaluation for drug screening, development, and drug delivery applications.

AB - Bioprinted skin tissue has the potential for aiding drug screening, formulation development, clinical transplantation, chemical and cosmetic testing, as well as basic research. Limitations of conventional skin tissue engineering approaches have driven the development of biomimetic skin equivalent via 3D bioprinting. A key hope for bioprinting skin is the improved tissue authenticity over conventional skin equivalent construction, enabling the precise localization of multiple cell types and appendages within a construct. The printing of skin faces challenges broadly associated with general 3D bioprinting, including the selection of cell types and biomaterials, and additionally requires in vitro culture formats that allow for growth at an air-liquid interface. This paper provides a thorough review of current 3D bioprinting technologies used to engineer human skin constructs and presents the overall pipelines of designing a biomimetic artificial skin via 3D bioprinting from the design phase (i.e. pre-processing phase) through the tissue maturation phase (i.e. post-processing) and into final product evaluation for drug screening, development, and drug delivery applications.

KW - 3D bioprinting

KW - Artificial skin

KW - Skin tissue engineering

KW - Tissue engineering

UR - http://www.scopus.com/inward/record.url?scp=85050780977&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050780977&partnerID=8YFLogxK

U2 - 10.1016/j.addr.2018.07.016

DO - 10.1016/j.addr.2018.07.016

M3 - Review article

C2 - 30055210

AN - SCOPUS:85050780977

VL - 132

SP - 270

EP - 295

JO - Advanced Drug Delivery Reviews

JF - Advanced Drug Delivery Reviews

SN - 0169-409X

ER -